V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20041293 | 20086174 | 1.65 | 87.6 | Adjuvant (A) | 2017-03-24 | 2017-03-24 | ECarboX | 02 | N | CISPLATIN + CYTARABINE + ETOPOSIDE + RITUXIMAB | 101837732 |
| 20041356 | 20086175 | 1.86 | 45.8 | null | 2017-05-17 | 2017-05-22 | Hydroxycarbamide | 02 | N | CAPECITABINE + STREPTOZOCIN | 101478358 |
| 20041369 | 20086176 | 1.7 | 112 | Adjuvant (A) | 2016-09-27 | 2016-10-07 | CISPLATIN + VINORELBINE + RT | N | N | MITOMYCIN | 100858576 |
| 20041407 | 20086177 | 1.54 | 64 | Adjuvant (A) | 2019-06-02 | 2019-06-20 | CARBOPLATIN + GEMCITABINE | 01 | N | DOCETAXEL | 100365859 |
| 20041408 | 20086178 | 1.78 | 90 | 03 | null | 2015-06-14 | RALTITREXED | N | N | CYCLOPHOSPHAMIDE + GEMCITABINE + RITUXIMAB + VINCRISTINE | 100302980 |
| 20041465 | 20086179 | null | 87.25 | null | 2017-09-28 | 2017-10-17 | Carbo F | 02 | N | FOXTROT TRIAL | 101035874 |
| 20041503 | 20086181 | 1.77 | 88.7 | null | 2018-08-17 | 2018-08-17 | null | 02 | N | NAB-PACLITAXEL | 100726145 |
| 20041510 | 20086182 | null | 11.2 | Adjuvant (A) | 2019-01-08 | 2019-01-29 | EVEROLIMUS | 02 | N | NIVOLUMAB | 101416304 |
| 20041515 | 20086183 | 1.5 | 82 | Palliative (P) | 2019-09-20 | 2019-09-20 | Cisplatin + Radiotherapy | 02 | N | CISPLATIN + PEMETREXED | 101680811 |
| 20041527 | 20086184 | null | null | 03 | null | 2021-01-07 | FCarboSt | 99 | Y | CARBOPLATIN + DOCETAXEL + TRASTUZUMAB | 101475327 |
| 20041565 | 20086185 | 1.62 | 67.1 | Palliative (P) | null | 2017-04-25 | Everolimus 10mg | null | N | MCX | 101350071 |
| 20041686 | 20086186 | 1.78 | 85 | Palliative (P) | 2018-04-22 | 2018-04-23 | Everolimus 10mg | 02 | N | RITUXIMAB | 100979582 |
| 20041781 | 20086187 | 1.72 | 82.2 | Palliative (P) | 2016-10-02 | 2016-10-13 | SCOPE 2 TRIAL | null | N | HYDROXYCARBAMIDE | 100417694 |
| 20041810 | 20086188 | 1.75 | 88 | Adjuvant (A) | 2022-01-25 | 2022-02-26 | Cisplatin + Fluorouracil + RT 5day | 02 | N | CISPLATIN + FLUOROURACIL + RT | 101230047 |
| 20041883 | 20086189 | 1.78 | 62.8 | 03 | 2018-02-27 | 2018-03-09 | BORTEZOMIB + THALIDOMIDE | 02 | N | CARBOPLATIN + DOXORUBICIN + MITOMYCIN | 100552074 |
| 20041929 | 20086190 | 1.5 | 83.2 | null | 2020-04-06 | 2020-04-06 | ACELARATE Trial | N | N | MCX | 101731732 |
| 20041952 | 20086191 | 1.68 | 88 | Palliative (P) | null | 2017-03-31 | BCG Intravesical | null | N | PEMBROLIZUMAB + PEMETREXED | 100333579 |
| 20041958 | 20086192 | 1.89 | 73.6 | 03 | 2018-05-17 | 2018-05-17 | CAPECITABINE + OXALIPLATIN + RT | 02 | N | CARBOPLATIN + EPIRUBICIN | 100284433 |
| 20041971 | 20086193 | null | 77 | 03 | 2017-11-16 | 2017-12-15 | PEMBROLIZUMAB | 02 | Y | IRINOTECAN + MDG + PANITUMUMAB | 100137970 |
| 20041995 | 20086194 | 1.65 | 59.8 | Palliative (P) | 2017-05-23 | 2017-06-06 | ECarboX | 02 | N | GEMCARBO | 101719705 |
| 20042041 | 20086195 | null | 20.7 | null | 2018-03-07 | 2018-03-29 | Chlorambucil | 02 | N | EVEROLIMUS | 101006702 |
| 20042090 | 20086196 | 1.74 | 67.8 | Adjuvant (A) | 2019-12-17 | 2019-12-17 | null | 02 | N | CISPLATIN + TEYSUNO | 100728956 |
| 20042123 | 20086197 | null | 54 | null | 2019-07-28 | 2019-07-28 | ECarboX | 01 | N | DARATUMUMAB | 100738570 |
| 20042181 | 20086198 | 1.56 | 79.1 | 03 | 2016-12-24 | 2016-12-31 | null | N | N | ACTICCA-1 TRIAL | 101219930 |
| 20042371 | 20086204 | 1.7 | 91.1 | 03 | 2017-04-30 | 2017-05-12 | CTD | 2 | Y | CYCLOPHOSPHAMIDE + EPIRUBICIN | 100875445 |
| 20042424 | 20086205 | 1.64 | 85 | Adjuvant (A) | 2018-03-04 | 2018-03-30 | MIC | 01 | N | IBRUTINIB | 101856767 |
| 20042457 | 20086206 | 0 | 69.95 | null | 2016-07-27 | 2016-08-13 | Ralitrexed | 02 | null | EOF | 100091951 |
| 20042482 | 20086207 | 1.59 | 63 | Palliative (P) | null | 2018-11-09 | CARBOPLATIN + TEYSUNO | N | N | BENDAMUSTINE + RITUXIMAB | 101498038 |
| 20042527 | 20086208 | 1.7 | 80.2 | Palliative (P) | null | 2021-09-30 | EVEROLIMUS | 02 | Y | PACLITAXEL | 101327594 |
| 20042538 | 20086210 | 1.6 | 67.4 | Curative (C) | 2017-06-24 | 2017-06-24 | ARISTOTLE TRIAL | 02 | N | CAPECITABINE + STREPTOZOCIN | 101690824 |
| 20042564 | 20086211 | 1.68 | 61.5 | Palliative (P) | 2019-06-05 | 2019-06-11 | CISPLATIN + FLUOROURACIL + RT | 01 | N | CARBOPLATIN + FLUOROURACIL | 100708223 |
| 20042633 | 20086212 | 1.72 | 88 | 03 | 2019-06-23 | 2019-07-02 | MCX | 02 | N | GEMCARBO | 101713214 |
| 20042694 | 20086214 | 1.59 | 80 | 03 | 2017-08-29 | 2017-09-17 | CHOP R - 21 days | 02 | N | PACLITAXEL | 100045161 |
| 20042742 | 20086215 | 1.56 | 86.4 | Palliative (P) | 2019-05-03 | 2019-05-03 | CARBOPLATIN + EPIRUBICIN | 02 | N | PANITUMUMAB | 101603217 |
| 20042750 | 20086216 | 1.88 | 62.7 | Palliative (P) | null | 2018-05-04 | Irinotecan 14day | 01 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 101152332 |
| 20042763 | 20086217 | 1.55 | 71.9 | 03 | 2019-08-10 | 2019-08-10 | EOF | 02 | N | NEO-AEGIS TRIAL | 101534223 |
| 20042790 | 20086218 | 1.78 | 69.7 | 03 | null | 2016-11-03 | FCiSt | N | N | CAPECITABINE + OXALIPLATIN + TRASTUZUMAB | 101117493 |
| 20042836 | 20086219 | 1.79 | 61.9 | null | 2019-11-17 | 2019-11-20 | CHOP R - 21 days | 02 | N | GEMCITABINE + OXALIPLATIN | 101718046 |
| 20042846 | 20086220 | 1.73 | 99.5 | 03 | 2018-07-29 | 2018-08-21 | Docetaxel | 02 | N | NEO-AEGIS TRIAL | 100010627 |
| 20042896 | 20086221 | 1.64 | 79.8 | Palliative (P) | 2018-11-28 | 2018-11-28 | EEF or EOF | 02 | N | EPIRUBICIN + FLUOROURACIL + OXALIPLATIN | 100396409 |
| 20042983 | 20086223 | 0 | 6.9 | Palliative (P) | 2020-04-07 | 2020-04-20 | PEMBROLIZUMAB | 2 | N | FOXTROT TRIAL | 101599674 |
| 20043059 | 20086224 | 1.56 | 59.8 | Curative (C) | 2017-04-23 | 2017-05-17 | SCOPE 2 TRIAL | 02 | N | IDARUBICIN + METHOTREXATE + VINCRISTINE | 100792774 |
| 20043074 | 20086225 | 1.87 | 85.57 | 03 | 2017-01-11 | 2017-01-22 | Paclitaxel 7 day | 02 | N | PAZOPANIB | 101219172 |
| 20043101 | 20086226 | 1.69 | 59.8 | Palliative (P) | 2019-01-23 | 2019-01-24 | EOF | 02 | N | GEMCITABINE + PACLITAXEL | 101823991 |
| 20043114 | 20086227 | 1.77 | 107.7 | null | 2016-04-04 | 2016-04-12 | EVEROLIMUS | N | N | FLUOROURACIL + RT | 100560187 |
| 20043123 | 20086228 | 1.67 | 72.5 | Palliative (P) | 2018-06-21 | 2018-06-23 | CARBOPLATIN + GEMCITABINE | 02 | N | CHOP | 101147785 |
| 20043164 | 20086229 | 1.86 | 50.3 | 03 | 2018-08-09 | 2018-08-23 | Hepatoblastoma SR Cisplatin | 02 | N | BENDAMUSTINE + RITUXIMAB | 100089170 |
| 20043165 | 20086230 | 1.8 | 73.3 | Adjuvant (A) | 2017-03-30 | 2017-03-30 | Cisplatin + Docetaxel +Fluorouracil | N | N | EVEROLIMUS | 100306450 |
| 20043171 | 20086231 | 1.65 | 72 | Palliative (P) | 2015-10-28 | 2015-10-30 | FCarboSt | 02 | N | TEMOZOLOMIDE | 100243407 |
| 20043173 | 20086232 | 1.73 | 106.4 | 03 | 2017-03-25 | 2019-08-17 | Irinotecan | 02 | N | PHITT D SIOPEL-4 (A1, A2, A3) | 100167234 |